“Preclinical Evaluation of the Innovative MK-7 NE: Toxicity Assessment and Safety Optimization in In Vivo Models”, Int. J. Pharm. Sci. Drug Res., vol. 17, no. 3, pp. 216–226, May 2025, doi: 10.25004/IJPSDR.2025.170301.